Mobile Mindfulness Meditation for Cancer-Related Anxiety and Neuropathy: Protocol for a Randomized Controlled Trial.
JMIR research protocols February 12, 2024 Ariel Siritorn Orasud, Mai Uchiyama, Ian Pagano et al. 3 citations
Anxiety and cancer-related neuropathy are common long-term effects of cancer treatment. Mindfulness meditation delivered through a mobile app may help manage these symptoms, especially for survivors with physical or geographic limitations. This paper describes an ongoing randomized waitlist-controlled trial evaluating the Mindfulness Coach app. Cancer survivors who completed primary treatment and experienced anxiety or neuropathy (200 per condition) were recruited. Data are collected at baseline, 8 weeks, and 16 weeks. The trial compares treatment and waitlist groups separately for each condition, assessing anxiety, neuropathy, pain, fatigue, trauma, sleep, and app satisfaction. Results are expected in early 2024. The approach aims to make mindfulness meditation accessible to more survivors.